{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T20:32:19Z","timestamp":1775766739511,"version":"3.50.1"},"reference-count":14,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","msard-journal.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Multiple Sclerosis and Related Disorders"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.msard.2021.103420","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T15:23:35Z","timestamp":1638199415000},"page":"103420","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis"],"prefix":"10.1016","volume":"57","author":[{"given":"R.","family":"Piedrabuena","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Bittar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.msard.2021.103420_bib0001","doi-asserted-by":"crossref","DOI":"10.1016\/j.msard.2016.07.007","article-title":"Increasing prevalence of multiple sclerosis in Buenos Aires, Argentina","author":"Cristiano","year":"2016","journal-title":"Mult. Scler. Relat. Disord."},{"issue":"13","key":"10.1016\/j.msard.2021.103420_bib0002","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1056\/NEJM200009283431307","article-title":"Multiple Sclerosis","volume":"343","author":"Noseworthy","year":"2000","journal-title":"NEJM"},{"key":"10.1016\/j.msard.2021.103420_bib0003","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.jns.2013.09.027","article-title":"Assessment of structural and functional visual outcomes in relapsing remitting multiple sclerosis with visual evoked potential and optical coherence tomography","volume":"335","author":"Tugcu","year":"2013","journal-title":"J. Neurol. Sci."},{"issue":"22","key":"10.1016\/j.msard.2021.103420_bib0004","doi-asserted-by":"crossref","first-page":"2085","DOI":"10.1212\/01.wnl.0000294876.49861.dc","article-title":"Optical coherence tomography and disease subtype in multiple sclerosis","volume":"69","author":"Pulicken","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.msard.2021.103420_bib0005","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neucli.2009.12.001","article-title":"Correlation between functional and structural assessmentin the optic nerve and retina in multiple sclerosis patients","volume":"40","author":"Almarcegui","year":"2010","journal-title":"Clin. Neurophysiol."},{"key":"10.1016\/j.msard.2021.103420_bib0006","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2147\/EB.S139417","article-title":"Retinal imaging with optical coherence tomography: a biomarker in multiple sclerosis?","volume":"10","author":"Costello","year":"2018","journal-title":"Eye and Brain"},{"issue":"10","key":"10.1016\/j.msard.2021.103420_bib0007","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1177\/1352458514524293","article-title":"Optical coherence tomography and visual evoked potentials: which is more sensitive in multiple sclerosis?","volume":"20","author":"Di Maggio","year":"2014","journal-title":"Mult. Scler. J."},{"key":"10.1016\/j.msard.2021.103420_bib0008","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0168-5597(97)00063-4","article-title":"Impaired VEP after photostress response in multiple sclerosis patients previously affected by optic neuritis","volume":"108","author":"Parisi","year":"1998","journal-title":"Electroencephalogr. Clin. Neurophysiol."},{"issue":"6","key":"10.1016\/j.msard.2021.103420_bib0009","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.nrl.2014.09.003","article-title":"An\u00e1lisis del grosor macular y de capa de fibras nerviosas en pacientes con esclerosis m\u00faltiple en relaci\u00f3n con su nivel de gravedad y antecedentes previos de neuritis \u00f3ptica","volume":"31","author":"Soler Garcia","year":"2016","journal-title":"Neurologia"},{"issue":"2","key":"10.1016\/j.msard.2021.103420_bib0010","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1177\/1352458517740216","article-title":"Peripapillary retinal nerve fibre layer as measured by optical coherence tomography is a prognostic biomarker not only for physical but also for cognitive disability progression in multiple sclerosis","volume":"25","author":"Bsteh","year":"2019","journal-title":"Mult. Scler. J."},{"issue":"5","key":"10.1016\/j.msard.2021.103420_bib0011","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/s41433-017-0010-2","article-title":"Optical coherence tomography in multiple sclerosis","volume":"32","author":"Britze","year":"2018","journal-title":"Eye (Lond.)"},{"issue":"6","key":"10.1016\/j.msard.2021.103420_bib0012","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/S1474-4422(16)00068-5","article-title":"Retinal thickness measured with optical coherence tomography and risk of disability worsening in multiple sclerosis: a cohort study","volume":"15","author":"Martinez-Lapiscina","year":"2016","journal-title":"Lancet Neurol."},{"issue":"2","key":"10.1016\/j.msard.2021.103420_bib0013","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.pjnns.2017.10.009","article-title":"Optical coherence tomography in diagnosis and monitoring multiple sclerosis","volume":"52","author":"Kucharczuk","year":"2018","journal-title":"Neurol. Neurochir. Pol."},{"key":"10.1016\/j.msard.2021.103420_bib0014","doi-asserted-by":"crossref","DOI":"10.3389\/fneur.2020.618879","article-title":"Optical Coherence Tomography and Optical Coherence Tomography Angiography Findings After Optic Neuritis in Multiple Sclerosis","author":"Murphy","year":"2020","journal-title":"Front. Neurol."}],"container-title":["Multiple Sclerosis and Related Disorders"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821006866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2211034821006866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,30]],"date-time":"2024-12-30T16:36:42Z","timestamp":1735576602000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2211034821006866"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":14,"alternative-id":["S2211034821006866"],"URL":"https:\/\/doi.org\/10.1016\/j.msard.2021.103420","relation":{},"ISSN":["2211-0348"],"issn-type":[{"value":"2211-0348","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optical coherence tomography and visual evoked potential and its relationship with neurological disability in patients with relapsing-remitting multiple sclerosis","name":"articletitle","label":"Article Title"},{"value":"Multiple Sclerosis and Related Disorders","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.msard.2021.103420","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"103420"}}